Types of Monoclonal Antibodies: A Scientific Guide

Monoclonal antibodies (mAbs) are antibodies produced from a single B-cell clone or an engineered equivalent and designed to recognize a specific antigen or epitope. They are widely used in biomedical research, diagnostics, biotechnology and therapeutic development.

What Are Monoclonal Antibodies?

A monoclonal antibody is an antibody population with a defined specificity for a particular molecular target. Unlike polyclonal antibody preparations, which contain antibodies produced by multiple B-cell clones, monoclonal antibodies are derived from a single clone and are intended to recognize the same antigenic target.

The development of hybridoma technology by Köhler and Milstein in 1975 established a method for producing antibodies with predefined specificity on a continuous basis and transformed immunology and biotechnology research.

What Are the Main Types of Monoclonal Antibodies?

1. Murine Monoclonal Antibodies

Murine monoclonal antibodies are derived entirely from mouse antibody sequences. They were central to the early development of monoclonal antibody technology and continue to be valuable research reagents.

They are commonly used in applications such as immunohistochemistry, flow cytometry, protein detection, cell characterization and laboratory immunoassays.

2. Chimeric Monoclonal Antibodies

Chimeric monoclonal antibodies combine antibody regions from different species. A traditional chimeric format uses a non-human variable region together with human constant regions.

The purpose is to preserve the antigen-binding characteristics of the original antibody while reducing the amount of foreign antibody sequence.

Examples

Examples traditionally classified as chimeric monoclonal antibodies include rituximab, infliximab and cetuximab.

3. Humanized Monoclonal Antibodies

Humanized monoclonal antibodies contain predominantly human antibody sequence while retaining engineered non-human regions required for specific antigen recognition.

One well-known humanization strategy is complementarity-determining region (CDR) grafting, in which antigen-binding CDR sequences from a non-human antibody are transferred onto human antibody framework regions.

Examples

Examples of antibodies traditionally classified as humanized include trastuzumab and several other therapeutic antibodies.

4. Fully Human Monoclonal Antibodies

Fully human monoclonal antibodies are designed to contain human antibody sequences throughout their structure and can be generated using several modern antibody-discovery technologies.

These include:

• Phage display
• Transgenic animal platforms
• Recombinant antibody technologies
• Single B-cell antibody discovery

Adalimumab is a well-known example of a fully human monoclonal antibody.

Comparison of the Four Main Types

Why Were Monoclonal Antibodies Humanized?

Early therapeutic antibodies were frequently derived from mice. Although they could recognize their intended targets, non-human antibody sequences could be recognized by the human immune system.

This encouraged the development of increasingly human antibody formats:

Monoclonal Antibodies Classified by Function

Monoclonal antibodies can also be classified according to their functional format, rather than only their species origin.

Monoclonal Antibodies in Biomedical Research

Monoclonal antibodies are indispensable research reagents because of their high target specificity.

• Western blotting
• ELISA
• Flow cytometry
• Immunohistochemistry
• Immunofluorescence
• Protein detection
• Cell characterization
• Receptor studies
• Biomarker research

Monoclonal Antibodies in Diagnostics

Monoclonal antibodies can be incorporated into diagnostic immunoassays designed to detect hormones, microbial antigens, cancer biomarkers, cell-surface proteins and other biological targets.

Depending on the assay architecture, monoclonal antibodies can function as capture antibodies, detection antibodies or both.

Monoclonal Antibodies in Cancer Research and Therapy

Cancer has been one of the major areas of monoclonal antibody development. Antibodies can recognize tumor-associated antigens or immune regulatory molecules.

Their mechanisms can include receptor blockade, immune-cell recruitment, immune checkpoint modulation and targeted delivery of therapeutic payloads.

Monoclonal Antibodies in Autoimmune and Inflammatory Diseases

Monoclonal antibodies are also used extensively in research and therapeutic development for immune-mediated diseases.

Potential targets include:

• Cytokines
• Cytokine receptors
• Immune-cell markers
• Adhesion molecules
• Immune regulatory proteins

How Are Monoclonal Antibodies Produced?

The classical production strategy is based on hybridoma technology. The general concept involves generating antibody-producing cells and establishing a continuous antibody-producing clone.

Traditional hybridoma development includes immunization, isolation of antibody-producing B cells, fusion with immortal myeloma cells, screening for desired specificity, clonal expansion and antibody production.

Modern antibody discovery has expanded considerably beyond conventional hybridomas and includes recombinant and display-based technologies.

Humanized vs. Fully Human Monoclonal Antibodies

Monoclonal Antibody Nomenclature

Historically, antibody names sometimes used suffixes that provided clues about molecular origin:

• -omab — murine
• -ximab — chimeric
• -zumab — humanized
• -umab — human

Frequently Asked Questions

Conclusion

The types of monoclonal antibodies are traditionally classified as murine, chimeric, humanized and fully human according to their molecular origin and engineering history.

Beyond this traditional classification, antibody technology now includes specialized formats such as antibody-drug conjugates, bispecific antibodies and radiolabeled antibodies.

These technologies have made monoclonal antibodies important tools across biomedical research, diagnostics, biotechnology, cancer research, immunology and therapeutic development.